Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Like I said. If the technology was so ground breaking, why did K2, Medtronic and Nuvasive all look at it and pass? They all did a detailed analysis on the technology and didn’t pick it up. That’s a fact and you simply cannot claim that it a superior material if the market does not agree.
It seems like you don’t understand market supply and demand. There is NO demand for this material.
Medtronic and Nuvasive both looked at their SiN cages and passed.
Call them up and check.
Nuvasive and Medtronic both passed on the technology. Wonder why.
Look at all the promises about ‘deals’ Amedica has made, BUT none have generated even one dollar. All I? care about is making money. Look at the facts!! Years go by and revenue just goes down.
The problem is you want to believe so hard that it’s going to happen. Kinda sad.
I know the truth is very hard to accept and to lash out at people who disagree with you.
It’s probably time to let go.
They have been implanting silicon nitride cages for about 9 years. How much time do they need? Like I? said, nobody is interested in their technology or else at this ‘bargain price’ it would have been picked up years ago. Large companies have looked at their technology and passed on it.
All noise. If SiN was such a great material, one of the big boys would have picked them up years ago, especially at the current price. It doesn’t take 2 years to do an acquisition on a small company. Market has moved on. That lost their window of opportunity.
So, no big announcement at NASS. Declining year over year SiN Sales. Market has moved on to 3D printed titanium cages with nanotechnology. Company running on fumes and nobody really cares about ceramic cages anymore.
Time to pull the plug on this one!
This seems to have been an mechanical test funded by Amedica. Giuseppe Pezzotti is on their scientific advisory board. its not unusual for companies to test competitive implants. No evidence that they are going to do a deal with Zimmer. Still speculation.
ALSO, address my other questions if you can. Re; Gen 2 cages.
ok, so your statement below is FALSE:
"I suggest you read their 10k because they have a strategic partner, Zimmer, whom they will commercialize their Hip implant with."
As an investor i only deal in facts, not speculation. very deceptive.
Where on the 10-k does it say Zimmer is a strategic partner?
Also, only difference between Valeo and gen 2 cages is that they made the gen 2 have a threaded connection to the inserter, not a squeeze grip connection. exact same material and process. Cages are machined from the green state pressed pucks and then fired.
They were able to modify the formula to increase the osteoblast proliferation which means reduced healing time.-> lol, nice try, show us the white papers on this.
Custom build cages for patient? Very impracticable. I guess you have no medical spine experience in the OR.
They have had the femoral head out for years, back in 2011. Nothing new there. Besides, they cannot bring it to market as they need to do a FDA clinical study which is going to cost millions of dollars which they don't have. Same for the knee, where are they going to get $$ to bring these to market and perform clinical trials which will take 4-5 years to complete? Gen 2 cages have been out for years, who cares that they are 3D printed, what does that do for the surgeon?. CSC been out for years, still no FDA approval.
Seems like all smoke and mirrors to us investors. Same old rhetoric we have been hearing for years.
https://www.beckersspine.com/orthopedic-a-spine-device-a-implant-news/item/3209-amedica.html
So, can someone tell me why they don't have any other products? Besides the Taurus screw, they haven't developed anything new in the last 5 years.The generation 2 silicon nitride cages and CSC were just modifications to their current SiN products.
No MIS screw system, no cervical plate to go with cervical cage, no posterior cervical system etc. Not moving very fast are they!
Seems like they are a one trick pony running out of tricks!
Why would they drop Kyocera? Kyocera was brought in as an additional manufacturer of silicon nitride o increase output as this was limited at Amedica.
Since sales volume has dropped off, they can produce every thing they need in house.
Well, NASS is coming up in a month, when all the big announcements are made. If we don't hear announcement by then, probably deal is dead.
It's also going to cost million of dollars to do a IDE with a multiple surgery centers collecting and analyzing the data for FDA submission.
By the way, are you the official correspondent for Amedica?
Actually, the Titanic eventually sank, just a FYI.
One also has to wonder why some people have spent so much time and effort in promoting this company and desperately trying to pump the stock, even after revenues dropping year after year, multiple reverse stock splits, no new FDA CSC launch. Actually it's quite impressive all the research that has gone into this! One can only wonder why.
Are you talking Worthington dental deal with a single dentist back in 2015? and no sales to China yet.
Taurus. Its basically the same as Preference with a modular headbody, no big deal. The helical flange has been on their preference screw from the beginning, nothing new there.
Why haven't they launched a MIS pedicle screw system yet? Huge market and they still don't have one! Most companies have a MIS screw system, except them. Maybe its because they only have one engineer and designer left in the building.
Ha. Got to love you guys! 'The Titanic is not sinking'. I remember over 2 years ago saying that cervical CSC would be approved back on the Yahoo message board.
As far as K2M is concerned, they used the SiN cages 2 years before their titanium cages came out, and stopped using them after 6 months due to intra operative issues.
Silicon Nitride sales have been dropping every quarter. Even with their generation 2 cages. Amedica missed their opportunity years ago and the market has now shifted to 3D printed titanium cages which can now be manufactured with the same radio lucency as SiN and Peek.
Amedica had an opportunity but didn't do the clinical research study's required. For years their only clinical data was a rat model comparing PEEK, SiN and Ti. Really!
Also, why did K2M which started using Amedica cages in Europe drop them, and then move to additive manufactured Ti cages?
A surgeon can't use the SiN cage as other metal cages. Most surgeons place a PLIF cage at 90 degrees into the disc space and then rotate it 90 degrees to jack up the disc height. 'Rotation Method'. The Amedica cage either breaks or the plastic tip on the threaded inserter fails when rotating. Doesn't work and frustrating to the surgeon. Most of these occurrences go unreported.
Because it's ceramic and it cracks. The interbody insertion instruments have plastic tips to try to prevent this. But they still break on occasions. Liability issues, that's why.
https://bankruptcompanynews.com/audit-concern-amedica/
Audit Concern for Amedica
BY KERRY MASTROIANNION SEPTEMBER 22, 2017
In Form 10-K filed on September 20, 2017, Amedica Corporation’s auditor, BDO USA, LLP, raised substantial doubt about the Company’s ability to continue as a going concern. According to BDO USA, the Company has recurring losses from operations and negative operating cash flows and needs to obtain additional financing to be compliant with debt covenants and to finance its operations. For the years ended December 31, 2016 and 2015, the Company incurred a net loss of $16.6 million and $23.9 million, respectively, and used cash in operations of $7.2 million and $9.1 million, respectively. The Company had an accumulated deficit of $213.1 million and $196.5 million at December 31, 2016 and 2015, respectively. The Company’s continuation as a going concern is dependent upon its ability to increase sales, implement cost saving measures, maintain compliance with debt covenants and/or raise additional funds through the capital markets. Read more on distressed companies.